Depending on how you respond to the study drugs and what the study doctor thinks is in your best interest, you may be able to receive an additional 13 cycles of treatment as described above (durvalumab and tremelimumab for 4 cycles and then 9 cycles of durvalumab alone). This is called retreatment. If you take part in retreatment, you will sign this informed consent form again.